Inhaled lodoxamide tromethamine in the treatment of perennial asthma: A double-blind placebo-controlled study
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 76 (1) , 83-90
- https://doi.org/10.1016/0091-6749(85)90808-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The protective effect of lodoxamide on antigen-induced bronchospasm. An orally active antiallergic drugJAMA, 1982
- Effect of inhaled lodoxamide tromethamine in prevention of antigen-induced bronchospasmJournal of Allergy and Clinical Immunology, 1981
- Protective effect of lodoxamide tromethamine on allergen inhalation challengeJournal of Allergy and Clinical Immunology, 1980
- Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drugJournal of Allergy and Clinical Immunology, 1980
- SODIUM CROMOGLYCATE-INDUCED CHANGES IN THE DOSE-RESPONSE CURVE OF INHALED METHACHOLINE AND HISTAMINE IN ASTHMATIC-CHILDRENPublished by Elsevier ,1979
- Antigen-induced neutrophil chemotactic activity in man *1Correlation with bronchospasm and inhibition by disodium cromoglycateJournal of Allergy and Clinical Immunology, 1978
- Inhibition of Allergic Reactions by Cromoglycate and by a New Antiallergy Drug U-42,585EInternational Archives of Allergy and Immunology, 1978
- Inhibition of Allergic Reactions by Cromoglycate and by a New Anti-Allergy Drug U-42,585EInternational Archives of Allergy and Immunology, 1978
- Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen MechanismsNature, 1967
- Antigen Induced Release of Histamine and SRS-A from Human Lung passively sensitized with Reaginic SerumNature, 1967